FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Strep topics
Streptococcus
Daptomycin
Antibiotic
Immunogenic
Nucleic Acid
Streptomyces
Pathogenic
Probiotics
Lactobacillus
Chromatograph
Antibiotics
Therapeutical
Chromatography
Solubility
Amino Acid

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Strep patents



      
           
This page is updated frequently with new Strep-related patents. Subscribe to the Strep RSS feed to automatically get the update: related Strep RSS feeds.

Subscribe to updates on this page: Strep RSS RSS

Date/App# patent app List of recent Strep-related patents
04/17/14
20140107061
 Novel strains of streptomyces microflavus and methods of their use to control plant diseases and pests patent thumbnailNovel strains of streptomyces microflavus and methods of their use to control plant diseases and pests
The present invention relates to novel strains of streptomyces microflavus and methods of their use for controlling diseases or pests of a plant. The invention also relates to a fermentation broth obtained by cultivating a gougerotin producing streptomyces strain, wherein the fermentation broth contains at least about 1 g/l gougerotin.
04/17/14
20140106406
 Gene cluster for the production of gougerotin, gougerotin analogues, and precursors thereof patent thumbnailGene cluster for the production of gougerotin, gougerotin analogues, and precursors thereof
The present disclosure relates to the molecular cloning of a gougerotin biosynthetic gene cluster from streptomyces microflavus, and identification of individual genes in the gene cluster as well as the proteins encoded thereby. A gougerotin gene cluster comprising 13 open reading frames (orfs) is located within a genetic locus of streptomyces microflavus.
04/17/14
20140105927
 Immunogenic composition patent thumbnailImmunogenic composition
For use in enhancing antibody-mediated opsonic activity against the targeted serotype of streptococcus pneumoniae.. .
04/17/14
20140105926
 Immunogenic composition patent thumbnailImmunogenic composition
The present invention relates to immunogenic compositions comprising one or more streptococcus pneumoniae capsular saccharide conjugates and a protein component comprising protein e and/or pila from haemophilus influenzae.. .
04/17/14
20140105862
 Streptomyces microflavus strains and methods of their use to control plant diseases and pests patent thumbnailStreptomyces microflavus strains and methods of their use to control plant diseases and pests
The present invention relates to novel strains of streptomyces microflavus and methods of their use for controlling diseases or pests of a plant. The invention also relates to a fermentation broth obtained by cultivating a gougerotin producing streptomyces strain, wherein the fermentation broth contains at least about 1 g/l gougerotin.
04/10/14
20140099339
 Vaccine against streptococcus pneumoniae patent thumbnailVaccine against streptococcus pneumoniae
The present invention relates to a combination of 2 or more s pneumoniae proteins, their manufacture and use in medicine as a vaccine. Such combinations are particularly useful for the protection of infants and elderly against streptococcal infection..
03/27/14
20140087398
 Oxidized cardiolipin and uses to detect cardiolipin antibodies patent thumbnailOxidized cardiolipin and uses to detect cardiolipin antibodies
Compositions, methods and devices for the detection of anti-lipoidal antibodies and the diagnosis of disease, for example, syphilis, are described. In particular, oxidized cardiolipins, which may be conjugated with a variety of attachment molecules, such as bsa, klh, biotin, synthetic protein maps, igy, streptavidin, or avidin, are described.
03/13/14
20140072963
 Electrochemiluminescence immunoassay method patent thumbnailElectrochemiluminescence immunoassay method
Disclosed is an electrochemiluminescence immunoassay method, using a full reaction of a ru(bpy) marked protein-primary antibody, a biotinylated protein-secondary antibody to be tested, and a sample to be tested; addition of a streptavidin-coated magnetic particle to form a complex comprising an antigen, an antibody, and a magnetic particle; adsorption to an electrode surface by the magnetic particle; addition of a dibutyl ethanolamine solution; testing by means of an electrochemical method. Also disclosed is a corresponding electrochemiluminescence immunoassay detection kit..
03/13/14
20140072622
 Vaccine against streptococcus pneumoniae patent thumbnailVaccine against streptococcus pneumoniae
The present invention relates to improved immunogenic compositions and vaccines, methods for making them and their use in medicine. In particular the invention relates to immunogenic compositions of unconjugated streptococcus pneumoniae proteins selected from: pneumolysin and member(s) of the polyhistidine triad family (e.g.
03/13/14
20140072549
 Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria patent thumbnailStreptococcus bacteriophage lysins for detection and treatment of gram positive bacteria
The present invention provides methods, compositions and articles of manufacture useful for the prophylactic and therapeutic amelioration and treatment of gram-positive bacteria, including streptococcus and staphylococcus, and related conditions. The invention provides compositions and methods incorporating and utilizing streptococcus suis derived bacteriophage lysins, particularly plyss2 and/or plyss1 lytic enzymes and variants thereof, including truncations thereof.
03/06/14
20140065218
Novel lactic acid bacteria and compositions containing them against bacterial colds
The invention describes a microorganism of the order of lactic acid bacteria or an analogue, fragment, derivative, mutant or combination thereof, wherein the microorganism, or analogue, fragment, derivative, mutant or combination thereof can coaggregate with streptococcus pyogenes.. .
02/27/14
20140057877
Therapeutic polyamine compositions and their synthesis
This invention relates to a process of synthesis and composition of open chain (ring), closed ring, linear branched and or substituted polyamines, polyamine derived tyrosine phosphatase inhibitors and ppar partial agonists/partial antagonists via a series of substitution reactions and optimizing the bioavailability and biological activities of the compounds. Polyamines prevent the toxicity of neurotoxins and diabetogenic toxins including paraquat, methyphenyl pyridine radical, rotenone, diazoxide, streptozotocin and alloxan.
02/27/14
20140057336
Biocontrol formulation containing streptomyces spp., method for preparing the formulation and relevant use
The present invention is a method for preparing a biocontrol formulation by the following steps. A streptomyces bacterium is selected simultaneously with superior sporulation ability, chitinase activity and antagonistic effectiveness against plant fungal pathogens by culturing with fungal pathogens, wherein the selected streptomyces bacterium is cultured on a chitin-limited plate to assess the ability of sporulation and chitinase activity, and the streptomyces bacterium with superior sporulation ability is the strain with producing powder-like and maturity form spore chains.
02/20/14
20140051650
Vaginal compositions based on alkyl polyglucosides
Compounds based on alkyl polyglycosides for use in the treatment of streptococcus agalactiae infections and other pathogens are provided. Such compounds may belong to the class of alkyl glucosides or alkyl polyglucosides.
02/20/14
20140051070
Streptavidin-coupled magnetic particles and manufacturing method for same
The streptavidin-coupled magnetic particle of the present invention, and the streptavidin-coupled magnetic particle manufactured by the manufacturing method of the present invention are useful in clinical diagnosis.. .
02/20/14
20140051036
Tooth filling materials and dental varnish for inhibiting the formation of a biofilm of streptococcus mutans and the production thereof
There are described tooth filling materials and dental varnishes for inhibiting the biofilm formation of streptococcus mutans containing (a) a quantity of an active substance for inhibiting the biofilm formation, (b) a material for forming a structure for the uptake and delayed release of the active substance and (c) a filling material system. Another aspect of this invention relates to a method for producing tooth filling materials or dental varnishes according to the invention for inhibiting the biofilm formation of streptococcus mutans.
02/20/14
20140050732
Combination for use in the treatment and/or prevention of mastitis
The present invention relates a combination for use in the treatment and/or prevention of mastitis containing i) an agonistic anti-cd40 monoclonal antibody or a cd40 ligand or a vector coding for the anti-cd40 antibody or a vector coding for the cd40l; and ii) inactivated or attenuated bacteria selected from the group consisting of staphylococcus, streptococcus, listeria or escherichia.. .
02/13/14
20140046043
C-4" position substituted macrolide derivative
A macrolide compound represented by the formula (i) effective against erythromycin resistant bacteria (for example, resistant pneumococci, streptococci and mycoplasmas).. .
02/06/14
20140037671
Immunogenic compositions for streptococcus pyogenes
The invention includes a gas antigen, gas 40, which is particularly suitable for use either alone or in combinations with additional gas antigens, such as gas 117, gas 130, gas 277, gas 236, gas 40, gas 389, gas 504, gas 509, gas 366, gas 159, gas 217, gas 309, gas 372, gas 039, gas 042, gas 058, gas 290, gas 511, gas 533, gas 527, gas 294, gas 253, gas 529, gas 045, gas 095, gas 193, gas 137, gas 084, gas 384, gas 202, and gas 057.. .
02/06/14
20140037669
Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (bhs) disease
A number of β-hemolytic streptococci polynucleotides and polypeptides, particularly streptococcus pyogenes polypeptides and polynucleotides, are described. Two or more of the polypeptides of the invention can be formulated for use as immunogenic compositions.
02/06/14
20140037553
Bacterium-based microrobot capable of targeting cancer tissue
To provide a bacterium-based microrobot which can be specifically targeted to cancer in vivo, the present invention provides a drug delivery system for cancer tissue, comprising a bacterium, and a microbead encapsulated with at least one drug, wherein biotin is bound to a surface of the bacterium and a surface of the microbead is coated with streptavidin.. .
01/30/14
20140030242
Antifungal composition comprising polycyclic peptide compound and method for preparing the same
Disclosed are a novel strain with antibacterial activity, identified as streptomyces sp. An1542 strain (accession no.: kctc 12113bp), an antibacterial composition comprising a compound represented by chemical formula 1 or 2, or a strain producing the same as an active ingredient, and a method for producing the same.
01/23/14
20140023620
Probiotic composition
Disclosed herein are probiotic compositions comprising a mixture of at least two probiotic bacteria, including streptococcus salivarius k12® (blis k12®) and at least a lactobacillus bacteria. The streptococcus salivarius k12® (blis k12®) may comprise streptococcus salivarius k12® (blis k12®) baa1024.
01/16/14
20140018303
3-amino-2-hydroxy-4-phenylbutanoyl-valyl-isoleucine, preparation and use thereof
The compound is prepared from fermentation culture streptomyces parvus cgmcc no. 4027 and is active as inhibitor of aminopeptidase.
01/16/14
20140017270
Small streptococcus pyogenes antigens and their use
The present invention relates to a peptide consisting of one antigen of streptococcus pyogenes (s. Pyogenes) of any of the seq id nos: 1 to 7 or a functional active variant thereof, optionally further consisting of additional amino acid residue(s); a nucleic acid coding for the same; a pharmaceutical composition, especially a vaccine, comprising said peptide or said nucleic acid; an antibody or functional active fragment thereof specifically binding to the antigen; a hybridoma cell line which produces said antibody; a method for producing said antibody; a pharmaceutical composition comprising said antibody; the use of said peptide or said nucleic acid for the manufacture of a medicament for the immunization or treatment of a subject; the use of said antibody or functional fragment thereof for the manufacture of a medicament for the treatment of an infection; a method of diagnosing a s.
01/16/14
20140017216
Pesticidal mixtures
The present invention relates to a pesticidal mixture comprising, as active i) at least one active compound i selected from the group consisting of the streptomyces galbus strain having accession number nrrl 30232, the streptomyces galbus strain having accession number nrrl 50334, a mutant of said strains, a variant of said strains, a metabolite produced by said strains, a supernatant obtained from the whole broth culture of said strains and a solvent extract of said supernatants, wherein said mutant and variant have the identifying characteristics substantially identical to those of said strains, and 2) at least one active compound ii selected from the groups a.i to a.27 as defined in the description, in synergistically effective amounts. .
01/09/14
20140011203
Uk-2 biosynthetic gene and method for improving uk-2 productivity using the same
The genomic dna of streptoverticillium sp. 3-7, which produces uk-2, was analyzed to identify a region expected to be a uk-2 biosynthetic gene cluster.
01/09/14
20140011183
Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
This invention is in the field of bacterial cultures and specifically relates to the optimization of culture conditions to improve the production of bacterial capsular polysaccharides from streptococcus strains in fed batch culture and to novel purification methods suitable for production scale purification of bacterial capsular polysaccharides from streptococcus strains resulting in higher levels of purity than previously obtained for production scale.. .
01/02/14
20140004144
Attenuated streptococcus suis vaccines and methods of making and use thereof
The present invention provides attenuated s. Suis strains that elicit an immune response in animal s.
01/02/14
20140004140
Group b streptococcus vaccine
This application relates to improved group b streptococcus (“gbs”) saccharide-based vaccines comprising combinations of gbs polysaccharides with polypeptide antigens, and vice versa, such that the polypeptide and the saccharide each contribute to the immunological response in a recipient. The combination is particularly advantageous where the saccharide and polypeptide are from different gbs serotypes.
12/26/13
20130345277
Modulators of gtpase and use in relevant treatment
The present invention relates to molecules which function as selective modulators of the ras-homologous (rho) family of small gtpases, in particular, cdc42 gtpase and their use to treat diseases, for example cancers, including metastatic cancer, genetic and acquired diseases where activation of cdc42 gtpase plays a pivotal role, such as neurodegenerative diseases, rheumatoid arthritis, atherosclerosis, diabetes type i, autosomal polycystic kidney disease, cystic kidney disease, precystic kidney disease, microbial infections, including chlamydia infections, e. Coli infections, h.
12/26/13
20130344477
Methods of capturing bindable targets from liquids
A bindable target such as a bacterial cell, virus, or molecule is captured from a liquid by contacting the liquid with magnetically attractable particles have an affinity for the target, and causing said particles to move repeatedly through said liquid to at least one solid support zone by attractive magnetic forces to capture the target onto said particles. The particles may be ferromagnetic, paramagnetic or superparamagnetic particles and may bear antibody, antibody binding fragments, a substance having an epitope capable of reacting in a specific manner with an antibody, an aptamer, a nucleic acid sequence or a nucleic acid analogue sequence, biotin, avidin or streptavidin.
12/26/13
20130344010
Oral health improving compositions
The present invention is concerned with microorganisms or fragments thereof as sensorically neutral oral care agents, particularly for prevention of dental calculus, as anti-caries agents and/or anti-oral malodor agents. The invention is furthermore concerned with compositions comprising microorganisms or fragments thereof for reducing mutans streptococci.
12/05/13
20130324423
New animal model for diabetic complications
The invention relates to the surprising find that low density lipoprotein receptor-deficient mice (ldlr−/−) mice when fed with high energy diets produce controllable and consistent diabetic complications, especially renal damage, similar to the human pathophysiology and biological response. The invention thus comprises a method for discovering a preventive or therapeutic regimen for the prevention or treatment of diabetic micro- or macrovascular complications, comprising the steps of: a.
11/28/13
20130316408
Marine streptomyces, pyranosesquiterpene compound, as well as preparation method and applications thereof
The invention discloses marine streptomyces sp., a pyranosesquiterpene compound, as well as a preparation method and uses thereof. Streptomyces sp.
11/28/13
20130315958
Pneumococcal serotypes
Disclosed is a new and emerging serotype of streptococcus pneumoniae designated serotype 6c, and assays and monoclonal antibodies useful in identifying same. Also disclosed is a novel pneumococcal polysaccharide with the repeating unit {2) glucose 1 (1→3) glucose 2 (1→3) rhamnose (1→3) ribitol (5→phosphate}.
11/28/13
20130315946
Vaccine composition against streptococcus pyogenes infection
The present invention relates to a vaccine composition against streptococcus pyogenes infection comprising an amino acid sequence having c-terminal fragment of streptococcal pyrogenic exotoxin b, and a pharmaceutical acceptable adjuvant.. .


Popular terms: [SEARCH]

Strep topics: Streptococcus, Daptomycin, Antibiotic, Immunogenic, Nucleic Acid, Streptomyces, Pathogenic, Probiotics, Lactobacillus, Chromatograph, Antibiotics, Therapeutical, Chromatography, Solubility, Amino Acid

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patents related to Strep for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Strep with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.2617

3276

0 - 1 - 72